• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Top Stories for the Week of Jan. 29th 2007

Top Stories for the Week of Jan. 29th 2007

January 30, 2007
CenterWatch Staff

Top News

Covance Builds Own Central Lab in Shanghai

Princeton, N.J.-based contract research organization Covance will be establishing its first fully owned central lab in China. Set to open by the fourth quarter of 2007, the new facility will be the company's fifth dedicated lab in its global network.China has restrictions on importing and exporting whole blood specimens, making the use of out-of-country testing facilities for some clinical trials impossible. Covance had thus far been using a partnering model with Huashan Hospital Center of Laboratory Medicine, Shanghai’s largest hospital.

PRA International Partners with US Oncology to Speed Cancer Trials

Virginia-based contract research organization (CRO) PRA International has set up a strategic clinical trials partnership with US Oncology Research, a national manager of cancer research centers. The partnership will be an alliance between the CRO and the network of investigative sites affiliated with US Oncology. PRA will align the two organizations’ internal processes and streamline the regulatory, patient recruitment and site qualification methods into one system.

Other Breaking News...

  • Hesperion opens Moscow office...
  • Parexel earnings jump...

Company Profile: An interview with Lisa Castro, president and chief executive officer, Sephmer Sciences

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Virtual Doctoer

    Simple Changes Can Make Trials More Patient Friendly

  • Drug approval

    Two-Thirds of Trial Subjects for Drug Approvals Are Outside the U.S.

  • VaccinewithNeedle-360x240.png

    Rules of Vaccine Approval May Be Changing, But Statistical Analysis Tools Remain Constant

  • AskTheExperts-360x240.png

    Ask the Experts: Trial Operations Adjustments in a Remote World

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing